Product Name

  • Name

    AMIKACIN

  • EINECS 253-538-5
  • CAS No. 37517-28-5
  • Article Data12
  • CAS DataBase
  • Density 1.6 g/cm3
  • Solubility water: 50 mg/mL, clear, colorless
  • Melting Point 203-204oC (sesquihydrate)
  • Formula C22H43N5O13
  • Boiling Point 981.8 °C at 760 mmHg
  • Molecular Weight 585.609
  • Flash Point 547.6 °C
  • Transport Information
  • Appearance
  • Safety 26-36
  • Risk Codes 36/37/38
  • Molecular Structure Molecular Structure of 37517-28-5 (AMIKACIN)
  • Hazard Symbols IrritantXi
  • Synonyms 1-N-[L-(-)-g-Amino-a-hydroxybutyryl]kanamycin A;Amukin;Antibiotic BB-K 8;Arikace;BB-K 8;Lukadin;Potentox;
  • PSA 331.94000
  • LogP -5.23210

Synthetic route

C67H133N5O15Si10

C67H133N5O15Si10

amikacin
37517-28-5

amikacin

Conditions
ConditionsYield
With hydrogen bromide In water pH=2 - 3;99.5%
C30H45N5O15

C30H45N5O15

amikacin
37517-28-5

amikacin

Conditions
ConditionsYield
With hydrazine hydrate for 4h; Reflux;99%
With hydrazine hydrate In water at 20℃; for 3h; Reflux;71.3%
With ammonium hydroxide
γ-phthalimidoimino-α-hydroxybutyric acid
40732-91-0

γ-phthalimidoimino-α-hydroxybutyric acid

silyl kanamycin A

silyl kanamycin A

amikacin
37517-28-5

amikacin

Conditions
ConditionsYield
Stage #1: γ-phthalimidoimino-α-hydroxybutyric acid With 2-Mercaptobenzothiazole; triethylamine In dichloromethane at 20℃; for 3h;
Stage #2: silyl kanamycin A In dichloromethane at 0 - 5℃; for 5h; Further stages;
93.6%
C16H20N2O4S2

C16H20N2O4S2

kanamycin A
59-01-8

kanamycin A

amikacin
37517-28-5

amikacin

Conditions
ConditionsYield
Stage #1: kanamycin A With chloro-trimethyl-silane; 1,1,1,3,3,3-hexamethyl-disilazane In acetonitrile Reflux;
Stage #2: C16H20N2O4S2 In acetone; acetonitrile at 0 - 5℃; for 1h;
Stage #3: With hydrogenchloride In water; acetone; acetonitrile for 1h; pH=2 - 3; Solvent; Reagent/catalyst; Temperature;
83%
C23H43N5O14

C23H43N5O14

amikacin
37517-28-5

amikacin

Conditions
ConditionsYield
Stage #1: C23H43N5O14 With sodium hydroxide at -16 - 15℃; for 0.25h; Green chemistry;
Stage #2: With sodium hypochlorite In water at -16 - -10℃; for 2h; Temperature; Hofmann Rearrangement; Green chemistry;
65.2%
amikacin sulfate
39831-55-5

amikacin sulfate

amikacin
37517-28-5

amikacin

Conditions
ConditionsYield
With Amberlite ion exchange resin (OH-form) In water for 1h;
C51H124N4O11Si11

C51H124N4O11Si11

amikacin
37517-28-5

amikacin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: acetone / 0.5 h
1.2: 0.5 h / 0 °C
2.1: hydrogenchloride / water / 1 h / pH 2.34
3.1: hydrazine hydrate / water / 3 h / 20 °C / Reflux
View Scheme
C54H109N5O15Si8

C54H109N5O15Si8

amikacin
37517-28-5

amikacin

Conditions
ConditionsYield
Stage #1: C54H109N5O15Si8 With hydrogenchloride In water for 1h; pH=3;
Stage #2: With hydrazine hydrate for 3h; Reflux;
C22H41BrN4O13

C22H41BrN4O13

amikacin
37517-28-5

amikacin

Conditions
ConditionsYield
With ammonia; potassium carbonate In acetone at 30℃; Temperature;
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

amikacin
37517-28-5

amikacin

tetra-N-Boc-amikacin

tetra-N-Boc-amikacin

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane; dichloromethane; water at 20℃;99%
amikacin
37517-28-5

amikacin

benzil
134-81-6

benzil

C78H75N5O17

C78H75N5O17

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water for 3h; Reflux;92%
amikacin
37517-28-5

amikacin

4-dimethylamino-benzaldehyde
100-10-7

4-dimethylamino-benzaldehyde

C58H79N9O13

C58H79N9O13

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water for 3h; Reflux;92%
amikacin
37517-28-5

amikacin

amikacin sulfate
39831-55-5

amikacin sulfate

Conditions
ConditionsYield
With sulfuric acid In ethanol; water at 10℃; for 6h; Temperature;91.5%
vanillin
121-33-5

vanillin

amikacin
37517-28-5

amikacin

C54H67N5O21

C54H67N5O21

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water for 3h; Reflux;91%
benzaldehyde
100-52-7

benzaldehyde

amikacin
37517-28-5

amikacin

C50H59N5O13

C50H59N5O13

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water for 3h; Reflux;90%
benzophenone
119-61-9

benzophenone

amikacin
37517-28-5

amikacin

C74H75N5O13

C74H75N5O13

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water for 3h; Reflux;90%
2-hydroxy-2-phenylacetophenone
119-53-9

2-hydroxy-2-phenylacetophenone

amikacin
37517-28-5

amikacin

C78H83N5O17

C78H83N5O17

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water for 3h; Reflux;89%
amikacin
37517-28-5

amikacin

acetophenone
98-86-2

acetophenone

C54H67N5O13

C54H67N5O13

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water for 3h; Reflux;89%
amikacin
37517-28-5

amikacin

acetone
67-64-1

acetone

C34H59N5O13

C34H59N5O13

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water for 3h; Reflux;89%
salicylaldehyde
90-02-8

salicylaldehyde

amikacin
37517-28-5

amikacin

C50H59N5O17

C50H59N5O17

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water for 3h; Reflux;88%
amikacin
37517-28-5

amikacin

3-phenyl-propenal
104-55-2

3-phenyl-propenal

C58H67N5O13

C58H67N5O13

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water for 3h; Reflux;87%
amikacin
37517-28-5

amikacin

N,N-dimethyl-formamide
68-12-2, 33513-42-7

N,N-dimethyl-formamide

C34H63N9O13

C34H63N9O13

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water for 3h; Reflux;86%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

amikacin
37517-28-5

amikacin

3,6',3",1'"-tetra-N-(tert-butoxycarbonyl)-amikacin

3,6',3",1'"-tetra-N-(tert-butoxycarbonyl)-amikacin

Conditions
ConditionsYield
With triethylamine In methanol79%
With triethylamine In methanol
5-benzoyl-3-(cyclopent-1-en-1-yl)-5-phenyl-1,5-dihydro-4H-pyrazol-4-one

5-benzoyl-3-(cyclopent-1-en-1-yl)-5-phenyl-1,5-dihydro-4H-pyrazol-4-one

amikacin
37517-28-5

amikacin

A

C29H47N5O14

C29H47N5O14

B

C36H51N5O15

C36H51N5O15

Conditions
ConditionsYield
In dimethyl sulfoxide at 20℃; for 12h; Solvent;A 77%
B 14%
amikacin
37517-28-5

amikacin

2-propenamide
79-06-1

2-propenamide

N-succinimidyl p-vinylbenzoate
97856-35-4

N-succinimidyl p-vinylbenzoate

5\'\'\-(p-vinylbenzoyl)amikacin-acrylamide copolymer, ratio: 10/90, Mr = 90 KDa; Monomer(s): 5\'\'\-(p-vinylbenzoyl)amikacin; acrylamide

5\'\'\-(p-vinylbenzoyl)amikacin-acrylamide copolymer, ratio: 10/90, Mr = 90 KDa; Monomer(s): 5\'\'\-(p-vinylbenzoyl)amikacin; acrylamide

Conditions
ConditionsYield
Stage #1: amikacin; N-succinimidyl p-vinylbenzoate With potassium carbonate In tetrahydrofuran; water at 20℃; for 1h;
Stage #2: 2-propenamide With α,α'-azodiizobutyramidine-dihydrochloride In water at 60℃; for 4h;
70%
4-Carboxybenzaldehyde
619-66-9

4-Carboxybenzaldehyde

amikacin
37517-28-5

amikacin

C30H47N5O15

C30H47N5O15

Conditions
ConditionsYield
With pyridine In dimethyl sulfoxide at 60℃; for 20h;70%
3-(cyclopent-1-en-1-yl)-5-(4-methoxybenzoyl)-5-phenyl-1,5-dihydro-4H-pyrazol-4-one

3-(cyclopent-1-en-1-yl)-5-(4-methoxybenzoyl)-5-phenyl-1,5-dihydro-4H-pyrazol-4-one

amikacin
37517-28-5

amikacin

A

C30H49N5O15

C30H49N5O15

B

C38H55N5O17

C38H55N5O17

Conditions
ConditionsYield
In dimethyl sulfoxide at 20℃; for 16h;A 70%
B 23%
heptafluorobutyric Acid
375-22-4

heptafluorobutyric Acid

amikacin
37517-28-5

amikacin

C-3-azidoamikacin tri(heptafluorobutyric acid)

C-3-azidoamikacin tri(heptafluorobutyric acid)

Conditions
ConditionsYield
Stage #1: amikacin With 1H-imidazole-1-sulfonyl azide hydrochloride; sodium hydroxide In aq. phosphate buffer at 20℃; for 18h; pH=8;
Stage #2: heptafluorobutyric Acid In acetone at 40℃; regioselective reaction;
65%
amikacin
37517-28-5

amikacin

C22H35N13O13

C22H35N13O13

Conditions
ConditionsYield
With triflic azide; triethylamine; zinc(II) chloride In methanol; water at 20℃; Inert atmosphere;64%
azidoacetic acid succinimidyl ester

azidoacetic acid succinimidyl ester

amikacin
37517-28-5

amikacin

C26H45N11O15

C26H45N11O15

Conditions
ConditionsYield
With potassium carbonate In methanol; water for 20h;26%
amikacin
37517-28-5

amikacin

C32H55N10O19P

C32H55N10O19P

Conditions
ConditionsYield
at 37℃; aminoglycoside-4'-nucleotidyltransferaze of Bacillus brevis, MgCl2, potassium phosphate buffer (pH 6.0);
amikacin
37517-28-5

amikacin

N-succinimidyl p-vinylbenzoate
97856-35-4

N-succinimidyl p-vinylbenzoate

A

N-{3-[5-amino-2-(4-amino-3,5-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-4-(6-aminomethyl-3,4,5-trihydroxy-tetrahydro-pyran-2-yloxy)-3-hydroxy-cyclohexylcarbamoyl]-3-hydroxy-propyl}-4-vinyl-benzamide

N-{3-[5-amino-2-(4-amino-3,5-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-4-(6-aminomethyl-3,4,5-trihydroxy-tetrahydro-pyran-2-yloxy)-3-hydroxy-cyclohexylcarbamoyl]-3-hydroxy-propyl}-4-vinyl-benzamide

B

N-{6-[6-amino-3-(4-amino-3,5-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-4-(4-amino-2-hydroxy-butyrylamino)-2-hydroxy-cyclohexyloxy]-3,4,5-trihydroxy-tetrahydro-pyran-2-ylmethyl}-4-vinyl-benzamide

N-{6-[6-amino-3-(4-amino-3,5-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-4-(4-amino-2-hydroxy-butyrylamino)-2-hydroxy-cyclohexyloxy]-3,4,5-trihydroxy-tetrahydro-pyran-2-ylmethyl}-4-vinyl-benzamide

C

C40H55N5O15

C40H55N5O15

Conditions
ConditionsYield
With potassium carbonate In tetrahydrofuran; water at 20℃; for 1h; Title compound not separated from byproducts;
amikacin
37517-28-5

amikacin

N-succinimidyl p-vinylbenzoate
97856-35-4

N-succinimidyl p-vinylbenzoate

poly[5''-(p-vinylbenzoyl)amikacin], Mr = 150 KDa; Monomer(s): 5''-(p-vinylbenzoyl)amikacin

poly[5''-(p-vinylbenzoyl)amikacin], Mr = 150 KDa; Monomer(s): 5''-(p-vinylbenzoyl)amikacin

Conditions
ConditionsYield
Stage #1: amikacin; N-succinimidyl p-vinylbenzoate With potassium carbonate In tetrahydrofuran; water at 20℃; for 1h;
Stage #2: With α,α'-azodiizobutyramidine-dihydrochloride In water at 60℃; for 8h;

Amikacin Chemical Properties

Product Name: Amikacin (CAS NO.37517-28-5)


Molecular Formula: C22H43N5O13
Molecular Weight: 585.6g/mol
Mol File: 37517-28-5.mol
Einecs: 253-538-5
Boiling point: 981.8 °C at 760 mmHg
Storage Temperature: 2-8°C
Flash Point: 547.6 °C
Density: 1.6 g/cm3
Water Solubility: 50 mg/mL, clear, colorless
Surface Tension: 103.2 dyne/cm
Enthalpy of Vaporization: 162.21 kJ/mol
Structure Descriptors of Amikacin (CAS NO.37517-28-5):
  InChI : InChI=1/C22H43N5O13/c23-2-1-8(29)20(36)27-7-3-6(25)18(39-22-16(34)15(33)13(31)9(4-24)37-22)17(35)19(7)40-21-14(32)11(26)12(30)10(5-28)38-21/h6-19,21-22,28-35H,1-5,23-26H2,(H,27,36)/t6-,7+,8-,9+,10+,11-,12+,13+,14+,15-,16+,17-,18+,19-,21+,22+/m0/s1 
  Smiles: O([C@H]1[C@@H](C[C@H](N)[C@H]([C@@H]1O)O[C@H]1O[C@@H]([C@@H](O)[C@@H]([C@H]1O)O)CN)NC([C@H](CCN)O)=O)[C@H]1O[C@@H]([C@@H](O)[C@@H]([C@H]1O)N)CO

Amikacin Uses

 Amikacin (CAS NO.37517-28-5) is most often used for treating severe, hospital-acquired infections with multidrug resistant Gram negative bacteria such as Pseudomonas aeruginosa, Acinetobacter, and Enterobacter.
Amikacin may be combined with a beta-lactam antibiotic for empiric therapy for people with neutropenia and fever.

Amikacin Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intramuscular 6200mg/kg (6200mg/kg)   Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975.
mouse LD50 intraperitoneal 750mg/kg (750mg/kg) PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) Antimicrobial Agents and Chemotherapy. Vol. 13, Pg. 41, 1978.
mouse LD50 intravenous 280mg/kg (280mg/kg)   Journal of Antibiotics. Vol. 43, Pg. 858, 1990.
mouse LD50 oral > 6gm/kg (6000mg/kg)   Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975.
mouse LD50 subcutaneous 6200mg/kg (6200mg/kg)   Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975.

Amikacin Safety Profile

Safety Information of Amikacin (CAS NO.37517-28-5):
Hazard Codes: XiIrritant
Risk Statements: 36/37/38
36:  Irritating to the eyes 
37:  Irritating to the respiratory system 
38:  Irritating to the skin 
Safety Statements: 26-36
26:  In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 
36:  Wear suitable protective clothing 

Amikacin Specification

 Amikacin ,its CAS NO. is 37517-28-5,the synonyms is 1-N-(L(-)-gamma-Amino-alpha-hydroxybutyryl)kanamycin A ; Amiglyde-V ; Amikacin Inhalation Solution ; Amikacinum ; Amikavet ; Antibiotic BB-K 8 ; BAY41-6551 ; BB-K 8 ; D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)- ; EINECS 253-538-5 ; HSDB 3583 ; Kaminax ; Lukadin ; Mikavir ; NSC 177001 ; O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(6-amino-6-
deoxy-alpha-D-glucopyranosyl-(1-6))-N(sup 3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine ; Pierami ; UNII-84319SGC3C ; D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)- ; D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->4))-N(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)- ; D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.4))-N1-((2S)-4-amino-2-hydroxy-1-oxobutyl)-2-deoxy- .

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View